Re: Removing plaque article
|
1
|
Resverlogix Corp.
|
Jun 27, 2017 02:37PM
|
Value
|
3
|
Resverlogix Corp.
|
Jun 29, 2017 04:29PM
|
Re: Reading the tea leaves.....
|
4
|
Resverlogix Corp.
|
Jul 03, 2017 03:45PM
|
Re: Did you know...?
|
1
|
Resverlogix Corp.
|
Jul 06, 2017 02:37PM
|
Share Price
|
1
|
Resverlogix Corp.
|
Jul 09, 2017 03:53PM
|
Re: Share Price
|
3
|
Resverlogix Corp.
|
Jul 09, 2017 05:45PM
|
Re: Resverlogix Randomizes First Patient in Taiwan/China Portion of the Phase 3 BETonMACE Clinical Trial
|
3
|
Resverlogix Corp.
|
Jul 10, 2017 03:20PM
|
Re: 002399:CH
|
2
|
Resverlogix Corp.
|
Jul 11, 2017 03:23PM
|
Re: 002399:CH
|
|
Resverlogix Corp.
|
Jul 11, 2017 04:48PM
|
Re: 002399:CH
|
|
Resverlogix Corp.
|
Jul 11, 2017 09:23PM
|
Re: 002399:CH
|
1
|
Resverlogix Corp.
|
Jul 11, 2017 09:29PM
|
Update
|
2
|
Resverlogix Corp.
|
Jul 12, 2017 10:55AM
|
Re: Update
|
4
|
Resverlogix Corp.
|
Jul 12, 2017 02:59PM
|
Re: Pascal Soriot
|
5
|
Resverlogix Corp.
|
Jul 13, 2017 10:37AM
|
Re: DM
|
2
|
Resverlogix Corp.
|
Jul 14, 2017 04:21PM
|
Re: Lobbying Firm and Resverlogix
|
2
|
Resverlogix Corp.
|
Jul 15, 2017 12:31PM
|
Re: Update
|
2
|
Zenith Epigenetics
|
Jul 15, 2017 12:40PM
|
Re: ZEN-3694 Single Agent Trial Status
|
3
|
Zenith Epigenetics
|
Jul 15, 2017 12:58PM
|
Re: ZEN-3694 Single Agent Trial Status
|
5
|
Zenith Epigenetics
|
Jul 18, 2017 03:19PM
|
Re: ZEN-3694 Single Agent Trial Status
|
1
|
Zenith Epigenetics
|
Jul 19, 2017 04:00PM
|